Cargando…
In vivo Drug Screening to Identify Anti-metastatic Drugs in Twist1a-ER(T2) Transgenic Zebrafish
Here, we present an in vivo drug screening protocol using a zebrafish model of metastasis for the identification of anti-metastatic drugs. A tamoxifen-controllable Twist1a-ER(T2) transgenic zebrafish line was established to serve as a platform for the identification. By crossing Twist1a-ER(T2) with...
Autores principales: | Nakayama, Joji, Makinoshima, Hideki, Gong, Zhiyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bio-Protocol
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213071/ https://www.ncbi.nlm.nih.gov/pubmed/37251091 http://dx.doi.org/10.21769/BioProtoc.4673 |
Ejemplares similares
-
Zebrafish-Based Screening Models for the Identification of Anti-Metastatic Drugs
por: Nakayama, Joji, et al.
Publicado: (2020) -
A zebrafish embryo screen utilizing gastrulation identifies the HTR2C inhibitor pizotifen as a suppressor of EMT-mediated metastasis
por: Nakayama, Joji, et al.
Publicado: (2021) -
Transgenic zebrafish for modeling hepatocellular carcinoma
por: Nakayama, Joji, et al.
Publicado: (2020) -
Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery
por: Stewart, Adam Michael, et al.
Publicado: (2015) -
An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening
por: Nguyen, Anh Tuan, et al.
Publicado: (2012)